Inventor · Chapel Hill, NC, US

Ryszard Kole

29Patents
15h-index
15Co-inventors
78Inventor score

Filing activity: Jan 26, 1995 → Sep 17, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US5976879A Antisense oligonucleotides which combat aberrant splicing and methods of using the same Chemistry; Metallurgy 149 Expired
US5916808A Antisense oligonucleotides which combat aberrant splicing and methods of using the same Chemistry; Metallurgy 138 Expired
US5665593A Antisense oligonucleotides which combat aberrant splicing and methods of using the same Chemistry; Metallurgy 114 Expired
US5627274A Antisense oligonucleotides which combat aberrant splicing and methods of using the same Chemistry; Metallurgy 113 Expired
US8865883B2 Multiple exon skipping compositions for DMD Chemistry; Metallurgy 89 Active
US8501703B2 Chimeric oligomeric compounds for modulation of splicing Chemistry; Metallurgy 87 Active
US8835402B2 Compound and method for treating myotonic dystrophy Chemistry; Metallurgy 78 Active
US8871918B2 Multiple exon skipping compositions for DMD Chemistry; Metallurgy 64 Active
US8741863B2 Compound and method for treating myotonic dystrophy Chemistry; Metallurgy 54 Active
US9447417B2 Multiple exon skipping compositions for DMD Chemistry; Metallurgy 52 Active
US9434948B2 Multiple exon skipping compositions for DMD Chemistry; Metallurgy 51 Active
US9447416B2 Multiple exon skipping compositions for DMD Chemistry; Metallurgy 35 Active
US9234198B1 Multiple exon skipping compositions for DMD Chemistry; Metallurgy 32 Active
US9453225B2 Multiple exon skipping compositions for DMD Chemistry; Metallurgy 23 Active
US9157081B2 Chimeric oligomeric compounds for modulation of splicing Chemistry; Metallurgy 23 Active
US9326992B2 Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA Chemistry; Metallurgy 15 Active
US9833468B2 Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA Chemistry; Metallurgy 11 Active
US9066967B2 Oligonucleotide analogues targeting human LMNA Chemistry; Metallurgy 3 Active
US10076536B2 Oligonucleotide analogues targeting human LMNA Chemistry; Metallurgy 2 Active
US10106796B2 Compound and method for treating myotonic dystrophy Chemistry; Metallurgy 1 Active
US9682097B2 Oligonucleotide analogues targeting human LMNA Chemistry; Metallurgy 1 Active
US10822608B2 Oligonucleotide analogues targeting human LMNA Chemistry; Metallurgy 1 Active
US10398721B2 Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA Chemistry; Metallurgy 0 Active
US11236329B2 Compound and method for treating myotonic dystrophy Chemistry; Metallurgy 0 Active
US11802283B2 Oligonucleotide analogues targeting human LMNA Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.